<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In rats with incomplete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> the effects of 70% <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> alone, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> alone (0.5 and 1 MAC), and the combination of <z:chebi fb="0" ids="29796">N2O </z:chebi>+ <z:chebi fb="0" ids="6015">isoflurane</z:chebi> on neurologic outcome, neurohistopathology, and EEG were compared </plain></SENT>
<SENT sid="1" pm="."><plain>Moderate and severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were produced by right carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> (moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, MAP = 30 mmHg, FIO2 = 0.30; severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, MAP = 25 mmHg, FIO2 = 0.20) </plain></SENT>
<SENT sid="2" pm="."><plain>Neurologic outcome was evaluated using a graded deficit score from 0 to 5 (0 = <z:mpath ids='MPATH_458'>normal</z:mpath>, 5 = <z:hpo ids='HP_0011420'>death</z:hpo> associated with <z:hpo ids='HP_0001297'>stroke</z:hpo>), and neurohistopathology was evaluated using a 40-point scale from 0 = <z:mpath ids='MPATH_458'>normal</z:mpath> to 40 = total hemisphere <z:mpath ids='MPATH_124'>infarct</z:mpath> at the level of the caudate nucleus in coronal section </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> alone, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> (0.5 and 1 MAC) improved neurologic outcome following moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (P less than 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> also decreased histopathologic damage following moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (<z:chebi fb="0" ids="17045,29796">N2O</z:chebi> control = 33 +/- 1 vs. 0.5 MAC <z:chebi fb="0" ids="6015">isoflurane</z:chebi> = 11 +/- 4 and 1 MAC <z:chebi fb="0" ids="6015">isoflurane</z:chebi> = 12 +/- 3, P less than 0.05), whereas only 0.5 MAC <z:chebi fb="0" ids="6015">isoflurane</z:chebi> decreased histopathologic damage following severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (<z:chebi fb="0" ids="17045,29796">N2O</z:chebi> control = 38 +/- 1 vs. 0.5 MAC <z:chebi fb="0" ids="6015">isoflurane</z:chebi> = 25 +/- 5; P less than 0.05) Adding <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> to 0.5 MAC <z:chebi fb="0" ids="6015">isoflurane</z:chebi> attenuated the neurologic protective effect of <z:chebi fb="0" ids="6015">isoflurane</z:chebi> alone and increased histopathologic damage following both moderate and severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (moderate = 23 +/- 5, severe = 37 +/- 2; both P greater than 0.05 compared with <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> controls) </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of adding 70% <z:chebi fb="0" ids="17045,29796">N2O</z:chebi> to <z:chebi fb="0" ids="6015">isoflurane</z:chebi> on cerebral blood flow (CBF) and cerebral oxygen consumption(CMRO2) was also evaluated.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>